Published in

American Association for the Advancement of Science, Science Translational Medicine, 486(11), 2019

DOI: 10.1126/scitranslmed.aav0537

Links

Tools

Export citation

Search in Google Scholar

Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activation

Journal article published in 2019 by Claire D. Bourke ORCID, Ethan K. Gough ORCID, Godfrey Pimundu, Annie Shonhai ORCID, Chipo Berejena, Louise Terry, Lucas Baumard ORCID, Naheed Choudhry ORCID, Yusuf Karmali, Mutsa Bwakura-Dangarembizi ORCID, Victor Musiime ORCID, Joseph Lutaakome, Adeodata Kekitiinwa, Kuda Mutasa, Alexander J. Szubert ORCID and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Cotrimoxazole reduces systemic and intestinal inflammation in HIV infection by suppressing gut-resident Streptococci and immune cell activation.